NDC Product Labeler Bsp Pharmaceuticals Srl

Bsp Pharmaceuticals Srl labeler's code is 43624. The labeler has 39 products that have an assigned National Drug Code.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Product Type	Status
43624-002	Halaven	Eribulin Mesylate	Injection	Intravenous	Human Prescription Drug	ACTIVE
43624-004		Loncastuximab Tesirine	Injection, Powder, Lyophilized, For Solution		Drug For Further Processing	UNFINISHED
43624-005		Pemetrexed Disodium Heptahydrate	Powder, For Solution		Drug For Further Processing	UNFINISHED
43624-006		Pemetrexed Disodium Heptahydrate	Powder, For Solution		Drug For Further Processing	UNFINISHED
43624-008		Sacituzumab Govitecan	Injection, Powder, Lyophilized, For Solution		Drug For Further Processing	UNFINISHED
43624-009		Bendamustine Hci Injection	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-010		Bendamustine Hci Injection	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-012		Mirvetuximab Soravtansine Gynx	Injection		Drug For Further Processing	UNFINISHED
43624-013		Vestronidase Alfa-vjbk	Injection		Drug For Further Processing	UNFINISHED
43624-014		Enfortumab Vedotin-ejfv For Injection	Injection		Drug For Further Processing	UNFINISHED
43624-015		Tirzepatide	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-016		Tirzepatide	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-017		Tirzepatide	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-018		Tirzepatide	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-019		Tirzepatide	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-020		Tirzepatide	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-021		Patritumab Deruxtecan	Injection, Powder, Lyophilized, For Solution		Drug For Further Processing	UNFINISHED
43624-022		Cedazuridine And Decitabine	Tablet, Film Coated		Drug For Further Processing	UNFINISHED
43624-023		Enfortumab Vedotin-ejfv For Injection	Injection		Drug For Further Processing	UNFINISHED
43624-024		Bortezomib 3.5mg/vial	Injection, Powder, Lyophilized, For Solution		Drug For Further Processing	UNFINISHED
43624-025		Mirikizumab Inj 300 Mg/15ml Vial	Injection		Drug For Further Processing	UNFINISHED
43624-026		Mirikizumab Inj 300 Mg/15 Ml Vial Reform	Injection		Drug For Further Processing	UNFINISHED
43624-027		Denileukin Diftitox Lyo 300 Mcg/vial Cit	Injection		Drug For Further Processing	UNFINISHED
43624-028		Telisotuzumab Vedotin	Injection		Drug For Further Processing	UNFINISHED
43624-029		Telisotuzumab Vedotin	Injection		Drug For Further Processing	UNFINISHED
43624-030		Pembrolizumab And Berahyaluronidase Alfa	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-031		Pembrolizumab And Berahyaluronidase Alfa	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-032		Tar-200	Tablet		Drug For Further Processing	UNFINISHED
43624-033		Multiple-dose Tirzepatide Injection	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-034		Multiple-dose Tirzepatide Injection	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-035		Multiple-dose Tirzepatide Injection	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-036		Multiple-dose Tirzepatide Injection	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-037		Multiple-dose Tirzepatide Injection	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-038		Multiple-dose Tirzepatide Injection	Injection, Solution		Drug For Further Processing	UNFINISHED
43624-039		Pivekimab Sunirine Drug Product (dp)	Injection, Powder, Lyophilized, For Solution		Drug For Further Processing	UNFINISHED
43624-040		Trastuzumab Emtansine Drug Product 100 Mg	Injection, Powder, Lyophilized, For Solution		Drug For Further Processing	UNFINISHED
43624-041		Trastuzumab Emtansine Drug Product 160 Mg	Injection, Powder, Lyophilized, For Solution		Drug For Further Processing	UNFINISHED
43624-042		Polatuzumab Vedotin Lyophilized Vials 30 Mg	Injection, Powder, Lyophilized, For Solution		Drug For Further Processing	UNFINISHED
43624-043		Polatuzumab Vedotin Lyophilized Vials 140 Mg	Injection, Powder, Lyophilized, For Solution		Drug For Further Processing	UNFINISHED